Overview

Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer

Status:
Not yet recruiting
Trial end date:
2027-02-01
Target enrollment:
Participant gender:
Summary
Optimal Timing of Surgery combined with Maintenance Therapy in the Front-line Treatment of Advanced Ovarian Cancer
Phase:
Phase 2
Details
Lead Sponsor:
Shanghai Gynecologic Oncology Group
Collaborator:
Fudan University
Treatments:
Niraparib
Poly(ADP-ribose) Polymerase Inhibitors